AMN Healthcare Services, Inc.
HealthcareNYSE:AMN · New York Stock Exchange
+$0.01 today
Vol 0.62M · Avg 1.02M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$3.4B of revenue converted into -$32.4M of net income for the selected period. Gross margin is 27.9% and net margin is -2.4%, showing how much revenue survives after costs and taxes. EPS is $-0.87, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B -8.5% | $3.0B -21.3% | $3.8B -27.7% | $5.2B +31.6% | $4.0B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $2.0B -5.2% | $2.1B -18.7% | $2.5B -28.0% | $3.5B +31.9% | $2.7B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $774.1M -15.8% | $919.4M -26.4% | $1.2B -27.2% | $1.7B +31.1% | $1.3B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 28.3% -2.5pp | 30.8% -2.2pp | 33.0% +0.2pp | 32.7% -0.1pp | 32.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $593.0M -6.2% | $632.5M -16.4% | $756.2M -19.3% | $936.6M +28.2% | $730.5M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $740.9M -27.5% | $1.0B +12.2% | $911.2M -14.8% | $1.1B +28.6% | $831.6M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $156.6M -9.9% | $173.8M +8.0% | $160.9M +17.4% | $137.1M +32.2% | $103.7M | $374.2M | $1.2B | $631.8M |
| EBITDA | $101.1M +42.2% | $71.1M -85.8% | $499.4M -36.3% | $784.2M +34.8% | $581.7M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 3.7% +1.3pp | 2.4% -10.8pp | 13.2% -1.8pp | 15.0% +0.4pp | 14.6% | 5.6% | 46.3% | 42.0% |
| Operating Income | $33.2M +132.3% | -$102.7M -130.3% | $338.4M -47.7% | $647.1M +35.4% | $478.0M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 1.2% +4.7pp | -3.4% -12.4pp | 8.9% -3.4pp | 12.3% +0.3pp | 12.0% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $45.6M -34.8% | $69.9M +29.1% | $54.1M +34.0% | $40.4M +18.5% | $34.1M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$134.2M -92.0% | -$69.9M -29.1% | -$54.1M -34.0% | -$40.4M -18.5% | -$34.1M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$101.1M +41.4% | -$172.6M -160.7% | $284.3M -53.1% | $606.7M +36.7% | $443.9M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -3.7% +2.1pp | -5.8% -13.3pp | 7.5% -4.1pp | 11.6% +0.4pp | 11.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | -$5.4M +79.1% | -$25.6M -134.8% | $73.6M -54.7% | $162.7M +39.6% | $116.5M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$95.7M +34.9% | -$147.0M -169.8% | $210.7M -52.6% | $444.1M +35.6% | $327.4M | $4.9B | $4.8B | $4.7B |
| Net Margin | -3.5% +1.4pp | -4.9% -10.5pp | 5.6% -2.9pp | 8.5% +0.3pp | 8.2% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$2 +35.6% | -$4 -171.6% | $5 -46.0% | $10 +45.0% | $7 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$2 +35.6% | -$4 -171.8% | $5 -45.9% | $10 +45.4% | $7 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $38.5M +0.9% | $38.2M -2.5% | $39.2M -12.2% | $44.6M -6.5% | $47.7M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $38.5M +0.9% | $38.2M -2.9% | $39.3M -12.3% | $44.9M -6.6% | $48.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Butterfly Network, Inc.
NYSE:BFLY
$1.45B
COMPASS Pathways plc
NASDAQ:CMPS
$1.16B
Nutex Health, Inc.
NASDAQ:NUTX
$859.80M
HealthStream, Inc.
NASDAQ:HSTM
$763.39M
Replimune Group, Inc.
NASDAQ:REPL
$733.24M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$722.58M
Evolent Health, Inc.
NYSE:EVH
$539.91M
Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
$515.41M
Myriad Genetics, Inc.
NASDAQ:MYGN
$408.96M
AirSculpt Technologies, Inc.
NASDAQ:AIRS
$377.42M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does AMN generate?
AMN Healthcare Services, Inc. (AMN) reported $2.73B of revenue in fiscal 2025.
Is AMN profitable?
AMN Healthcare Services, Inc. (AMN) reported -$95,702,000.00 of net income, with a net margin of -3.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.